Business
Co-Founder of Nasdaq Global Corporate Solutions Group Joins Board of THC Therapeutics-THCT
Co-Founder of Nasdaq Global Corporate Solutions Group Joins Board of THC Therapeutics-THCT.
About this update from Thc Therapeutics, Inc.
[{"type":"text","content":"\nEnzo Villani brings over 20 years of experience in developing businesses through “buy and build” strategies leveraging strategic partnerships, M&A, and business development.\n LAS VEGAS, May 06, 2019 (GLOBE NEWSWIRE) -- THC Therapeutics, Inc. (THCT), a forward-thinking publicly traded cannabis company whose mission statement is \"Better Health through the Science of Nature\", is pleased to announce Enzo Villani was appointed a member of the Company’s Board of Directors. Mr. Villani has raised over $500 million in funding from strategic investors, private equity, venture capital, family offices and the public markets during his over twenty year career. Previously, Mr. Villani has held executive positions as chief strategy officer and co-founder including co-founding Nasdaq Global Corporate Solutions Group. Mr. Villani was the chief strategy officer and co-founder of DF King Worldwide, where he completed a $200 million strategic M&A roll-up backed by private equity firm The Riverside Company. DF King Worldwide was formed from a consolidation of tier-1 shareholder communications firms servicing over 2,000 public company clients with services in market intelligence, investor relations, proxy solicitation, investor targeting, shareholder communications, and corporate governance. Mr. Villani was a member of the board of MZ Group, Sao Paulo, Brazil, where he was engaged in a global consolidation strategy backed by private equity fund Jardim Botanico in the United States and China. Mr. Villani  has completed over 15 acquisitions over 6 continents. From 2014 to 2017, he served as CEO of Equities.com, the world’s largest middle-market and emerging growth company content publisher, growing the business 300% over three years. Currently, he is Managing Partner of Thrust Capital, Ltd. and Transform Group. Mr. Villani holds an M.B.A. from The Johnson School at Cornell University and a B.A. from Iona College. Brandon Romanek, Founder & CEO of THC Therapeutics, said, “I am excited to have Mr. Villani, who has intimate experience with shareholder communications and the public markets, engaged as a Board member of THC Therapeutics. Mr. Villani is bringing his vast experience with Wall Street and access to capital markets to help facilitate the expansion of THCT. His addition to the team demonstrates...